Antiproliferative agents include Mycophenolic acid and Azathioprine (which is less commonly used unless in certain conditions). They were initially identified for use in autoimmune and cancer research due to their role in disruption of cellular replication. They have now become the cornerstone of antirejection maintenance therapy in solid organ transplant. In this chapter we will describe the major times that lead to discovery, mechanisms of action, side effects, use during pregnancy and the major clinical trials.
CITATION STYLE
Donovan, R., Eisen, H., & Ali, O. (2022). Antiproliferatives and Transplantation. In Handbook of Experimental Pharmacology (Vol. 272, pp. 39–52). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/164_2021_556
Mendeley helps you to discover research relevant for your work.